Gene · 84148
Papers2,655
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,655
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lysine acetyltransferase 8-mediated histone acetylation, regulated by GBA1, is associated with lysosomal function related to α-Synuclein pathology. | Cell Death Dis | 2026 | 42252285 | PubTator, text mining | PubMed |
| MOF Network Scaffold Engineering: Inducing Cd/Zn-Based MOF Structural Variations via Metal Nodes and Intermolecular Interactions for Long-Persistent Luminescence Regulation. | Inorg Chem | 2026 | 42228775 | PubTator, text mining | PubMed |
| Electrostatic Effect-Induced Eu/UiO-66 MOF Regulation for Rapid and Selective Recognition of PFOA. | Anal Chem | 2026 | 42199069 | PubTator, text mining | PubMed |
| CDK1 Phosphorylates KAT8 at Ser348 to Stabilize the MSL Complex and Promote H4K16 Acetylation in Non-Small Cell Lung Cancer. | Cells | 2026 | 42193906 | PubTator, text mining | PubMed |
| K49 acetylation of ACSL4 antagonizes its ubiquitination degradation and promotes tumorigenesis in hepatocellular carcinoma. | Cancer Lett | 2026 | 42167396 | PubTator, text mining | PubMed |
| Tetrazole-Decorated Ultramicroporous MOF Exhibiting Inverse CO2 Selectivity for Hydrocarbon Purification. | ACS Appl Mater Interfaces | 2026 | 42163459 | PubTator, text mining | PubMed |
| Crystal Engineering of Intrinsic Dynamicity in Metal-Organic Frameworks for Adaptive Multicomponent Catalysis. | Angew Chem Int Ed Engl | 2026 | 42131983 | PubTator, text mining | PubMed |
| Hierarchical small molecule inhibition of MYST acetyltransferases. | Nat Commun | 2026 | 42129151 | PubTator, text mining | PubMed |
| Amorphous/Crystalline Interface of LDH-MOF Heterostructure Enables Efficient Oxygen Evolution Reaction. | Small | 2026 | 42117301 | PubTator, text mining | PubMed |
| MOF-based composite catalysts for CO2 reduction: Recent advances and perspectives. | Environ Res | 2026 | 42055384 | PubTator, text mining | PubMed |
| High-Current Oxygen Evolution via Synergistic Ag Incorporation in Zn-Based Metal-Organic Framework Electrocatalysts. | Inorg Chem | 2026 | 42010962 | PubTator, text mining | PubMed |
| Enhancing gas sensing recyclability and recovery rate by crystal engineering of CuI motif in MOFs. | Nat Commun | 2026 | 42000750 | PubTator, text mining | PubMed |
| Machine learning potential for modelling dynamic hydrogen bond networks in MOF MIL-120. | Chem Sci | 2026 | 41982918 | PubTator, text mining | PubMed |
| Dual Active Sites in a Single MOF: Achieving High-Rate and Selective Photocatalytic CO2 Reduction to Formate With Concurrent Water Oxidation. | Angew Chem Int Ed Engl | 2026 | 41978360 | PubTator, text mining | PubMed |
| Process-dependent inhibitory effects of zinc-based metal-organic frameworks on nitrifying microbial consortia. | Bioresour Technol | 2026 | 41967519 | PubTator, text mining | PubMed |
| Correction to "Ultrasound Trigger Ce-Based MOF Nanoenzyme For Efficient Thrombolytic Therapy". | Adv Sci (Weinh) | 2026 | 41955461 | PubTator, text mining | PubMed |
| Correction to "Magnesium Ion/Gallic Acid MOF-Laden Multifunctional Acellular Matrix Hydrogels for Diabetic Wound Healing". | ACS Appl Bio Mater | 2026 | 41954131 | PubTator, text mining | PubMed |
| Tackling Orientational Isomerism in Metal-Organic Frameworks Comprising Low-Symmetry Linker Molecules via Simulated Annealing Featuring a Neural Network Potential. | J Comput Chem | 2026 | 41925167 | PubTator, text mining | PubMed |
| Disrupting KAT8 Liquid-Liquid Phase Separation with Hybrid Vesicle-Liposome Platform for Enhanced PD-L1 Blockade Treatment. | Adv Mater | 2026 | 41919648 | PubTator, text mining | PubMed |
| Stage-specific epigenetic priming amplifies gene activation during lineage commitment. | Sci Adv | 2026 | 41894493 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84148/papers?page=3